PCR275 Patient Experience With Anti–Vascular Endothelial Growth Factor (VEGF) Therapy in Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): A Multinational Survey
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2208
https://www.valueinhealthjournal.com/article/S1098-3015(22)04413-8/fulltext
Title :
PCR275 Patient Experience With Anti–Vascular Endothelial Growth Factor (VEGF) Therapy in Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): A Multinational Survey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04413-8&doi=10.1016/j.jval.2022.09.2208
First page :
Section Title :
Open access? :
No
Section Order :
11765